KOR

e-Article

A novel variant of fructose‐1,6‐bisphosphatase gene identified in an adult with newly diagnosed hepatitis C
Document Type
article
Source
JIMD Reports, Vol 63, Iss 2, Pp 109-113 (2022)
Subject
FBP1 gene
fructose‐1,6‐bisphosphatase deficiency
gluconeogenesis
hepatitis C
hypoglycaemia
inborn errors of fructose metabolism
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
Genetics
QH426-470
Language
English
ISSN
2192-8312
Abstract
Abstract Hepatic fructose‐1,6‐bisphosphatase (FBPase) deficiency commonly presents with acute crises during infancy when glycogen stores are depleted. In these patients, dependence on glycogenolysis means that the duration of normoglycaemia is related to liver glycogen stores. Clinical hallmarks of FBPase deficiency include hypoglycaemia and lactic acidosis with or without ketosis. Patients commonly present with hyperventilation, vomiting, tachycardia, reduced consciousness and glucagon‐resistant hypoglycaemia. Between crises, patients are usually well with normal growth and development; however significant ingestion of fructose, sucrose or glycerol during acute crises may be fatal, hence the importance of a prompt diagnosis. We present the case of a 30‐year‐old male who presented to our tertiary centre acutely unwell, shortly following a diagnosis of hepatitis C, which we speculate may have precipitated this severe presentation. He had similar, milder episodes throughout childhood. Furthermore, a pathological homozygous sequence variant in fructose‐1,6‐bisphosphatase (FBP1) gene, previously unreported, was identified. Diagnosis in adulthood is underreported in the literature, however, represents an important, albeit rare, cause of hypoglycaemia and lactic acidosis.